NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.99% |
VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.92% |
EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.89% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.87% |
UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.82% |
AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.81% |
GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.78% |
INSM | Insmed Inc | Healthcare | Biotechnology | 1.76% |
MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.71% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.67% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.65% |
INCY | Incyte Corporation | Healthcare | Biotechnology | 1.63% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.62% |
REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.59% |
BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.48% |
EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.47% |
KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 1.40% |
BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.37% |
TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | 1.21% |
This website uses cookies. To learn more about cookies, please see our privacy policy .